Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy-Reference-Cited by-同舟云学术

Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy

Published:2015-10 Issue:10 Volume:5 Page:e009566
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Pushpakom Sudeep P^ORCID,Taylor Claire,Kolamunnage-Dona Ruwanthi,Spowart Catherine,Vora Jiten,García-Fiñana Marta,Kemp Graham J,Whitehead John,Jaki Thomas,Khoo Saye,Williamson Paula,Pirmohamed Munir

Publisher

BMJ

Subject

General Medicine

Reference55 articles.

1. The National Cholesterol Education Program—Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes;Lorenzo;Diabetes Care,2007

2. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study;Carr;Lancet,2003

3. Lipodystrophy—a sign for metabolic syndrome in patients of the HIV-HEART study;Potthoff;J Dtsch Dermatol Ges,2010

4. Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects;Paula;AIDS Res Ther,2013

5. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome;Worm;AIDS,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. gsMAMS: an R package for Designing Multi-Arm Multi-Stage Clinical Trials;Journal of Open Source Software;2024-05-28

2. Methodological review to develop a list of bias items for adaptive clinical trials: Protocol and rationale;2024-04-26

3. Group sequential multi‐arm multi‐stage trial design with treatment selection;Statistics in Medicine;2023-02-20

4. Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs;BMC Medicine;2020-11-19

5. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design;BMJ;2020-06-17